Cargando…
CXCR4-Targeted Necrosis-Inducing Peptidomimetic for Treating Breast Cancer
[Image: see text] Triple-negative breast cancer is an aggressive subtype with a high recurrence rate, potential for metastasis, and a poor prognosis. The chemokine receptor, CXCR4, is a promising molecular target in breast cancer therapy. Here, we have developed a CXCR4-targeted antitumor peptidomim...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339399/ https://www.ncbi.nlm.nih.gov/pubmed/37457445 http://dx.doi.org/10.1021/acsomega.3c02415 |